LIC increases its stake in Dr Reddy's Laboratories to 7.7 pc – ETHealthWorld

We have updated our terms and conditions and privacy policy
Click “Continue” to accept and continue with ET HealthWorld
Dear user,

ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.

You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.

If you choose to ignore this message, we’ll assume that you are happy to receive all cookies on ET HealthWorld.
Japan’s Fujifilm stops work on Avigan as COVID drug
No review of once approved organ transplant: HC

25 February, 2022
25 February, 2022
25 November, 2022
1 Octuber, 2021

Rebooting Cancer Awareness
The unsung hero in faster holistic recovery
Technological Disruption in Indian Health & Pharma
Do you think you are up for the challenge?
Holistic Solutions For A Healthier India


Between June 15, 2022, and September 30, 2022, LIC purchased 33,86,486 shares of DRL, aggregating a 2.034 per cent stake from the open market, it added.
Recommended by ColombiaColumbia
125000+ Industry Leaders read it everyday
Home minister Amit Shah will launch medical education in Hindi in Madhya Pradesh by releasing translated MBBS first-year books in Bhopal on October 16.
StemOne has anti-inflammatory and immunosuppressive properties which reduce inflammation in the knee joint. It may initiate the repair process by differentiating into chondrocytes or by inducing proliferation and differentiation of endogenous chondro-progenitors into mature chondrocytes or both.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc.
Please contact us to know more details.
Get ETHealthworld‘s top stories every morning in your email inbox.
125000+ Industry Leaders read it everyday
Follow @ETHealthworld for the latest news, insider access to events and more.


Leave a Comment